|
**Overview**: PCOs Steroid Androgen Panel**Introduction**: The Polycystic Ovary Syndrome Steroid Androgen Panel is a diagnostic tool designed to screen for PCOS androgen levels using serum samples. In India, PCOS affects ~20-30 percent of reproductive-age women (higher in urban/obese), with hyperandrogenism causing hirsutism, acne, irregular cycles, and infertility. High morbidity from under-testing in rural/low-SES women with androgen excess, limited endocrine labs, delayed lifestyle/anti-androgen therapy leading to prolonged infertility or metabolic syndrome. Per endocrinology practices aligned with ICMR, Endocrine Society of India, and FOGSI guidelines, the test employs spectrophotometry for testosterone, DHEAS, and androstenedione over 1-2 days with high accuracy, valuable for confirming biochemical hyperandrogenism in Rotterdam criteria. This diagnostic falls under endocrine screening and targets women with hirsutism or oligomenorrhea, addressing accurate detection to guide metformin, OCPs, or ovulation induction. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise androgen profiling and reducing reproductive/metabolic burden. Its serum-based approach ensures reliable androgen measurement.**Other Names**: PCOS Androgen Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/endocrinology, compliant with 2025 standards.**Historical Milestone**: Androgen panel standard in PCOS diagnosis; in India, routine in gynecology.**Purpose**: The test assesses 3 parameters including testosterone to guide PCOS screening, detect hyperandrogenism, inform therapy.**Test Parameters**: 1. Testosterone, 2. DHEAS, 3. Androstenedione.**Pretest Condition**: Fasting 10-12 hours recommended; patients should have androgen excess symptoms.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve steroid integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on hirsutism, cycles.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected PCOS including infertility, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Elevated androgens support PCOS diagnosis, necessitating specialist input.**Specialist Consultation**: Endocrinologists or gynecologists should be consulted for management.**Additional Supporting Tests**: Pelvic ultrasound, LH/FSH ratio for confirmation.**Test Limitations**: Mild elevations nonspecific; comprehensive approach required.**References**: Indian Journal of Endocrinology 2024, PCOS Studies India 2023. |
